1 / 28

Diabetes Mellitus (DM)

Diabetes Mellitus (DM). By: Ms. Santoshi Naik Assistant Professor Yenepoya Pharmacy College and Research Centre. DEFINITION. DM is defined as a heterogeneous metabolic disorder characterized by chronic hyperglycemia with disturbance of carbohydrate, fat and protein metabolism.

wyates
Download Presentation

Diabetes Mellitus (DM)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Diabetes Mellitus(DM) By: Ms. Santoshi Naik Assistant Professor Yenepoya Pharmacy College and Research Centre

  2. DEFINITION • DM is defined as a heterogeneous metabolic disorder characterized by chronic hyperglycemia with disturbance of carbohydrate, fat and protein metabolism. • Diabetes is due to either the pancreas not producing enough insulin or the cells of the body not responding properly to the insulin produced.

  3. Classification & Etiology of Diabetes Mellitus

  4. TYPE 1 DM • Earlier called Insulin-dependent(IDDM) because it was known that these patients have absolute requirement for insulin replacement as treatment, or juvenile-onset diabetes due to its occurrence in younger age. • Incidence of occurrence – 10% cases of Diabetes Mellitus.

  5. Type 2 DM • Earlier called Non-insulin-dependent or maturity-onset diabetes since it predominantly affects older individuals but, it is now known that it also occurs in obese adolescent children. • It is characterised by insulin resistance (sensitization of insulin receptors), impaired or delayed insulin secretion & excessive or inappropriate glucagon secretion. • Incidence of occurrence – 80% cases of Diabetes Mellitus.

  6. Other specific types of Diabetes • Genetic defect of β-cell function due to mutations in various enzymes (earlier called maturity-onset diabetes of the young or MODY). • Genetic defect in insulin action (e.g. type A insulin resistance). • Diseases of exocrine pancreas (e.g. chronic pancreatitis, pancreatic tumours, post-pancreatectomy). • Endocrinopathies (e.g. acromegaly, Cushing's syndrome).

  7. Drug- or chemical-induced (e.g. steroids, thyroid hormone, thiazides, β-blockers etc). • Infections (e.g. congenital rubella). • Other genetic syndromes (e.g. Down's syndrome, Turner's syndrome).

  8. Gestational DM • About 4% pregnant women develop DM due to metabolic changes during pregnancy. • Although they revert back to normal glycaemia after delivery, these women are prone to develop DM later in their life.

  9. PATHOGENESIS OF DIABETES MELLITUS

  10. Depending upon etiology of DM, hyperglycaemia may result from the following: • Reduced insulin secretion • Reduced insulin action • Decreased glucose use by the body • Increased glucose production

  11. Normal Insulin Metabolism

  12. Pathogenesis of Type 1 DM • The basic phenomenon in type 1 DM is destruction of β-cell mass, usually leading to absolute insulin deficiency. • Pathogenesis of type 1ADM is explained on the basis of 3 mutually-interlinked mechanisms. • Genetic susceptibility • In identical twins - 50% chance of the second twin • About half the cases with genetic predisposition have the susceptibility gene located in the HLA region of chromosome 6.

  13. 2) Autoimmune Factors • Presence of islet cell antibodies against GAD (glutamic acid decarboxylase), insulin etc. • Occurrence of lymphocytic infiltrate in and around the pancreatic islets termed insulitis. • Selective destruction of beta cells while other islet cell types remain unaffected. • Assocaition of type 1A DM with other autoimmune diseases such as Graves disease, Addisons disease, etc.

  14. 3) Environmental Factors: • Certain viral infections eg: mumps, measles etc. • Experimental induction of type 1A DM with certain chemicals has been possible. eg alloxan, pentamidine, etc. • Geographic and Seasonal Variations. • Possible relationship of early exposure to bovine milk proteins.

  15. Pathogenesis of Type 2 DM • The basic metabolic defect in type 2 DM is either delayed insulin secretion (impaired insulin secretion) or the peripheral tissues are unable to respond to insulin (insulin resistance) or excess glucagon secretion. 1. Genetic Factors • There is approximately 80% chance of developing diabetes in the other identical twin if one twin has the disease. • A person with one parent having type 2 DM is at an increased risk of getting diabetes, but if both parents have type 2 DM the risk in the offspring rises to 40%.

  16. 2. Constitutional Factors • Certain environmental factors such as obesity, hypertension, and level of physical activity play contributory role and modulate the disease. 3. Insulin Resistance • Lack of responsiveness of peripheral tissues to insulin. • Mechanism of Hyperglycemia in these cases is explained as under: a) Resistance to action of insulin impairs glucose utilisation and hence hyperglycaemia b) There is increased hepatic synthesis of glucose. c) Hyperglycaemia in obesity is related to high levels of free fatty acids and cytokines.

  17. 4. Impaired Insulin Secretion • In type 2 DM, insulin resistance and insulin secretion are interlinked : • Early in the course of disease, in response to insulin resistance there is compensatory increased secretion of insulin (hyperinsulinaemia) in an attempt to maintain normal blood glucose level. • Eventually there is failure of beta cell function to secrete adequate insulin, although there is some secretion of insulin i.e. cases of type 2 DM have mild to moderate deficiency of insulin but not its total absence.

  18. 5. Increased Hepatic Glucose Synthesis • One of the normal roles played by insulin is to promote hepatic storage of glucose as glycogen and suppress gluconeogenesis. In Type 2 DM, as a part of insulin resistance by peripheral tissues, liver also shows insulin resistance. • This results in increased hepatic synthesis of glucose which contributes to hyperglycaemia in these cases.

  19. Pathogenesis

  20. COMPLICATIONS OF DM

  21. Acute Metabolic Complications • Ketoacidosis and hypoglycaemia are complications of Type 1 DM. • Hyperosmolar hyperglycemicnonketotic coma is complication of Type 2 DM. • Diabetic ketoacidosis: • A serious diabetes complication where the body produces excess blood acids (ketones). • Symptoms: anorexia, nausea, vomiting, deep and fast breathing, mental confusion and coma.

  22. Development of Ketoacidosis

  23. 2. Hyperosmolar hyperglycaemic nonketotic coma (HHS) • It is caused by severe dehydration resulting from sustained hyperglycaemic diuresis. • The loss of glucose in urine is so intense that the patient is unable to drink sufficient water to maintain urinary fluid loss. 3. Hypoglycaemia • It may result from excessive administration of insulin, missing a meal, or due to stress. • Hypoglycaemia produces permanent brain damage.

  24. Late Metabolic Complications • Complications may develop after 15-20 yrs. • Late complications are largely responsible for premature mortality in diabetes mellitus. • Atherosclerosis • Diabetes mellitus of both type 1 and type 2 accelerates the development of atherosclerosis. • Causes: hyperlipidaemia, reduced HDL levels, obesity and associated hypertension in diabetes

  25. 2. Diabetic microangiopathy • Microangiopathyof diabetes is characterised by basement membrane thickening of small blood vessels and capillaries of different organs and tissues such as the skin, skeletal muscle, eye and kidney. 3. Diabetic nephropathy • Renal involvement is a common complication and a leading cause of death in diabetes. 4. Diabetic neuropathy • Diabetic neuropathy may affect all parts of the nervous system.

  26. 5. Diabetic retinopathy • Diabetic retinopathy is a leading cause of blindness – damage to retina of the eye. • Diabetes also predisposes the patients to early development of cataract and glaucoma. 6. Infections • Diabetics have enhanced susceptibility to various infections such as tuberculosis, pneumonias, otitis and diabetic ulcers.

More Related